Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Chengbang Pharmaceutical Technology is a specialized pharmaceutical service provider based in China, focusing on the research, development, and manufacturing of high-quality pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company offers a range of CRO and CDMO services, including custom synthesis, process optimization, and scale-up production for small molecule therapeutics. Chengbang Pharmaceutical serves a global clientele, providing technical support and chemical solutions to accelerate drug discovery and development. Their facilities are equipped for complex chemical synthesis and adhere to rigorous quality control standards. The company is committed to innovation in chemical processes to reduce costs and improve efficiency for its partners in the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 杭州成邦医药科技.